Apr 2019 $2 M No. 6 $2 to $10 million 3
Tragara Pharmaceuticals Inc: Raise no. 6, Apr 2019 × Investors in this round 3 investors had bought by the notice of Apr 24, 2019: 3 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $2 M of $12 M offered; $10 M still to sell
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Lynne R. Rollins · Executive Officer Scott M. Megaffin · Executive Officer, Director Tracy M. Lawhon · Executive Officer Alain R. Schreiber · Director Chris E. Christoffersen · Director Dennis M. Podlesak · Director Eckard R. Weber · Director Grigory Borisenko · Director Mauro Bove · Director Thomas M. Estok · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Lynne R. Rollins, Chief Financial Officer. Source: SEC Form D, newest notice filed Apr 24, 2019. Read the notice at the SEC .
equity, options SEC Nov 2016 $3 M No. 5 $2 to $10 million 3
Tragara Pharmaceuticals Inc: Raise no. 5, Nov 2016 × Investors in this round 3 investors had bought by the notice of Nov 15, 2016: 3 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $3 M of $5 M offered; $2 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Dennis E. Bilski · Executive Officer Thomas M. Estok · Executive Officer, Director Tracy M. Parrott · Executive Officer Alain P. Schreiber · Director Eckard P. Weber · Director Evgeny E. Zaytsev, M.D. · Director Kim P. Kamdar · Director Mauro E. Bove · Director Ralph E. Christoffersen · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Thomas M. Estok, President and Chief Executive Officer. Source: SEC Form D, newest notice filed Nov 15, 2016. Read the notice at the SEC .
equity SEC Aug 2015 $13 M No. 4 $10 to $50 million 7
Tragara Pharmaceuticals Inc: Raise no. 4, Aug 2015 × Investors in this round 7 investors had bought by the notice of Sep 2, 2015: 7 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $13 M of $13 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees $50,000
Paid to its own people $900,000 (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Dennis E. Bilski · Executive Officer Thomas M. Estok · Executive Officer, Director Tracy M. Parrott · Executive Officer Alain P. Schreiber · Director Eckard P. Weber · Director Evgeny E. Zaytsev, M.D. · Director Kim P. Kamdar · Director Mauro E. Bove · Director Ralph E. Christoffersen · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Thomas M. Estok, President and Chief Executive Officer. Source: SEC Form D, newest notice filed Sep 2, 2015. Read the notice at the SEC .
equity SEC Jul 2015 $1 M No. 3 Under $2 million 5
Tragara Pharmaceuticals Inc: Raise no. 3, Jul 2015 × Investors in this round 5 investors had bought by the notice of Jul 17, 2015: 5 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $1 M of $1 M offered
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Chris M. LeMasters · Executive Officer Thomas M. Estok · Executive Officer, Director Tracy M. Parrott · Executive Officer Alain P. Schreiber · Director Eckard P. Weber · Director Evgeny E. Zaytsev, M.D. · Director Kim P. Kamdar · Director Ralph E. Christoffersen · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Thomas M. Estok, President and Chief Executive Officer. Source: SEC Form D, newest notice filed Jul 17, 2015. Read the notice at the SEC .
debt, options SEC Jul 2012 $4 M No. 2 $2 to $10 million 4
Tragara Pharmaceuticals Inc: Raise no. 2, Jul 2012 × Investors in this round 4 investors had bought by the notice of Aug 8, 2012: 4 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $4 M of $6 M offered; $2 M still to sell
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Chris M LeMasters · Executive Officer Thomas M Estok · Executive Officer, Director Tracy M Parrott · Executive Officer Alain P. Schreiber · Director Eckard P. Weber · Director Kim P. Kamdar · Director Ralph E. Christoffersen · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Thomas M. Estok, President and Chief Executive Officer. Source: SEC Form D, newest notice filed Aug 8, 2012. Read the notice at the SEC .
debt, options SEC Jan 2010 $5 M No. 1 $2 to $10 million 7
Tragara Pharmaceuticals Inc: Raise no. 1, Jan 2010 × Investors in this round 7 investors had bought by the notice of Feb 4, 2010: 7 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $5 M of $10 M offered; $5 M still to sell
Smallest investment taken $1
What was sold equity
Meant to last more than a year
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Thomas M. Estok · Executive Officer, Director Alain B. Schreiber, M.D. · Director Eckard B. Weber, M.D. · Director Kim P. Kamdar, Ph.D. · Director Ralph E. Christoffersen, Ph.D. · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Thomas M. Estok, President and Chief Executive Officer. Source: SEC Form D, newest notice filed Feb 4, 2010. Read the notice at the SEC .
equity SEC